Title: A Clinicopathological Study of Penile Carcinoma in a Tertiary Care Hospital, Visakhapatnam

Authors: Dr Bogarapu Chaitanya Babu,M.S, Dr Chintagada Jayaraj, M.S.,Mch, Dr Yeeli Sivaram Shashank, Dr Ginjupalli Sai Chand, Dr Potireddy Yaswanth Reddy, Dr Jami Yaswanth Sai, Dr Gopisetty Siri, Dr Munagala Poornima Aishwarya

 DOI: https://dx.doi.org/10.18535/jmscr/v9i1.18

Abstract

Background: One of the countries with the highest incidence of penile cancer in the world is India, with rates up to 3.32 per 100 000 men in some regions. The vast majority of patients have an apparently localized disease at diagnosis, with high-risk characteristics for nodal involvement but without clinical evidence of such involvement. This suggests that the morbidity and mortality among these patients is underestimated.

Materials and Methods: A retrospective study was conducted on 30 cases of carcinoma penis in the Department of General Surgery, King George Hospital, Visakhapatnam, from June 2018 to June 2020. Patients presenting with symptoms suggestive of carcinoma penis were admitted, investigated using routine investigations, and USG/CT scan, and managed during this period. Factors studied were incidence among age, demography, time of presentation, presenting complaints, stage of presentation, and treatment options available in our setup.

Results: Out of 30 subjects,14(46.66%) are aged above 60 yrs,10(33.33%) are between 30 - 44yrs,6(20%) are between 45 - 59yrs. 10(20%) subjects presented with phimosis. 20 subjects are smokers. Stage of presentation:: STAGE 0: 4 (13.33%), STAGE 1 : 6 (20%) ,STAGE 2 : 6 (20%), STAGE 3A : 2(6.66%),STAGE 3B : 8(26.66%),STAGE 4: 4 (13.33%). Lymph nodal involvement is noted in 12(40%) cases. Carcinoma insitu 4 (13.33%),Well differentiated squamous cell carcinoma 12 (40%), Moderately differentiated squamouscell carcinoma 12 (40%), spindle cell carcinoma 2 (6.66%). Penectomy alone (Total/Partial): 20(66.66%) cases. Penectomy with inguinal block dissection (Unilateral/Bilateral): 8(26.66%) cases. Chemoradiation: 2(6.66%) cases

Conclusion: Though the disease condition is rare in younger populations it’s not uncommon in developing nations. Early diagnosis and treatment significantly reduce the morbidity. Lack of awareness and social stigmas plays key role in delayed presentation. Active surveillance and awareness programs help in reducing the disease burden. Smoking, as in many diseases, is a significant risk factor for carcinoma penis, its usage should be condemned

Keywords: penile cancer, phimosis, squamous cell carcinoma, penectomy.

References

  1. Mosconi, F. Roila, G. Gatta, and C. Theodorec, “Cancer of the penis,” Critical Reviews in Oncology/Hematology, vol. 53, pp. 165–177, 2005.
  2. Burgers JK, Badalament RA, Drago JR. Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am. 1992 May;19(2):247–56.
  3. Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A, Goodman MT, King JB, et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998– 2003. Cancer. 2008;113(November):2883–91.
  4. Burt LM, Shrieve DC, Tward JD. Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):94–100.
  5. Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control. 2001 Apr;12(3): 267–77.
  6. Daling JR, Madeleine MM, Johnson LG. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer2005;116:606–616.
  7. Maden C, Sherman KJ, Beckmann AM. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst1993;85:19–24.
  8. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int2001;88:473–483.
  9. Villavicencio, J. Rubio-Briones, R. Regalado, G. Chechile, F. Algaba, and J. Palou, “Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis,” European Urology, vol. 32, no. 4, pp. 442–447, 1997.
  10. Pizzocaro, L. Piva, G. Bandieramonte, and S. Tana, “Up-to-date management of carcinoma of the penis,” European Urology, vol. 32, no. 1, pp. 5–15, 1997.
  11. Soto Delgado, F. Arredondo Martínez, and G. Pedrero Márquez, “Cáncer de pene. Una revisión de 18 casos,” Actas Urologicas Espanolas, vol. 27, no. 10, pp. 797–802, 2003.
  12. Crook J. Radiation therapy for cancer of the penis. Urol Clin North Am 2010;37:435-443.
  13. DeKernion JB, Tynbery P, Persky L, Fegen JP. Proceedings: carcinoma of the penis. Cancer 1973;32: 1256–62.
  14. McDougal WS, Kirchner FK Jr, Edwards RH, Killion LT. Treatment of carcinoma of the penis: the case of primary lymphadenectomy. J Urol 1986; 136: 38–41.
  15. Lerner SE, Jones JG, Fleischmann J. Management of recurrent penile cancer following partial or total penectomy. Urol Clin North Am 1994; 21: 729–37.
  16. Jensen MO. Cancer of the penis in Denmak 1942 to 1962 (511 cases). Dan Med Bull 1977; 24: 66–72.
  17. Diz Rodr´ıguez, M. V´ırseda Chamorro, and I. Arance Gil, “Revisi´on de los tumores epidermoides de pene,” Actas Urologicas Espanolas, vol. 31, no. 1, pp. 7–10, 2007.
  18. Hunter-Mellado and P. Rodr´ıguez, “Squamous cell carcinoma of the penis,” Boletin de la Asociacion Medica de Puerto Rico, vol. 82, no. 9, pp. 416–418, 1990.

Corresponding Author

Dr Bogarapu Chaitanya Babu,M.S

Assistant Professor, Dept. of General Surgery